Compositions and methods for treating ocular diseases
AssigneeAerpio Therapeutics Inc.
InventorsKevin Peters, Robert Shalwitz
Life of this patent
Estimating the term…
Abstract
Disclosed herein are compositions and methods for treating ocular diseases, inter alia, diabetic macular edema, age-related macular degeneration (wet form), choroidal neovascularization, diabetic retinopathy, retinal vein occlusion (central or branch), ocular trauma, surgery induced edema, surgery induced neovascularization, cystoid macular edema, ocular ischemia, uveitis, and the like. These diseases or conditions are characterized by changes in the ocular vasculature whether progressive or non-progressive, whether a result of an acute disease or condition, or a chronic disease or condition.
Claims21
A method for treating an ocular disease, comprising administering to a subject in need thereof:
- a compound having the formula:
- or
- a pharmaceutically acceptable salt thereof;
- and
- at least one anti-VEGF agent, wherein the anti-VEGF agent is ranibizumab, bevacizumab, or aflibercept.
(canceled)
7-11. (canceled)
14-16. (canceled)
19-65. (canceled)
67-108. (canceled)
110-172. (canceled)
Dependencies are inferred from the claim text.